State of New Jersey Common Pension Fund D’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-126,693
Closed -$2.61M 1595
2023
Q3
$2.61M Buy
126,693
+78,292
+162% +$2.26M 0.01% 966
2023
Q2
$2.28M Sell
48,401
-6,624
-12% -$330K 0.01% 1510
2023
Q1
$2.31M Sell
55,025
-4,911
-8% -$211K 0.01% 1180
2022
Q4
$2.29M Hold
59,936
0.01% 1170
2022
Q3
$2.35M Sell
59,936
-9,898
-14% -$383K 0.01% 1002
2022
Q2
$2.26M Sell
69,834
-4,408
-6% -$148K 0.01% 1218
2022
Q1
$2.46M Buy
74,242
+5,571
+8% +$209K 0.01% 1404
2021
Q4
$2.92M Buy
68,671
+3,275
+5% +$137K 0.01% 1165
2021
Q3
$2.9M Buy
65,396
+30,354
+87% +$1.39M 0.01% 1138
2021
Q2
$1.99M Buy
35,042
+1,147
+3% +$81.1K 0.01% 1717
2021
Q1
$2.54M Sell
33,895
-1,696
-5% -$139K 0.01% 1300
2020
Q4
$3.08M Sell
35,591
-12,830
-26% -$946K 0.01% 1039
2020
Q3
$2.96M Sell
48,421
-4,322
-8% -$219K 0.01% 890
2020
Q2
$2.19M Buy
52,743
+14,220
+37% +$516K 0.01% 1241
2020
Q1
$1.11M Hold
38,523
0.01% 1404
2019
Q4
$2.78M Sell
38,523
-1,577
-4% -$194K 0.01% 1073
2019
Q3
$5.63M Buy
40,100
+25,100
+167% +$4.2M 0.02% 704
2019
Q2
$2.75M Hold
15,000
0.01% 688
2019
Q1
$2.39M Buy
15,000
+10,000
+200% +$1.45M 0.01% 713
2018
Q4
$479K Hold
5,000
﹤0.01% 872
2018
Q3
$706K Hold
5,000
﹤0.01% 871
2018
Q2
$783K Hold
5,000
﹤0.01% 888
2018
Q1
$805K Buy
+5,000
New +$849K ﹤0.01% 878

Other funds holding SAGE

State of New Jersey Common Pension Fund D's SAGE Position: Q4 2023 in Review

State of New Jersey Common Pension Fund D sold out of Sage Therapeutics (SAGE) in Q4 2023, closing a stake of 126,693 shares — an estimated $2.61M sold.

State of New Jersey Common Pension Fund D first reported a position in SAGE in Q1 2018 and held it in 23 quarters. The position peaked at $5.63M in Q3 2019. 201 funds tracked by Wall St. Rank hold SAGE as of Q4 2023.

  • State of New Jersey Common Pension Fund D reported no remaining Sage Therapeutics position as of Q4 2023 after selling out during the quarter.
  • State of New Jersey Common Pension Fund D sold 126,693 Sage Therapeutics shares in Q4 2023, an estimated $2.61M.
  • State of New Jersey Common Pension Fund D first reported a position in Sage Therapeutics in Q1 2018 and held it in 23 quarters.
  • State of New Jersey Common Pension Fund D's Sage Therapeutics position peaked at $5.63M in Q3 2019.
  • 201 funds tracked by Wall St. Rank held Sage Therapeutics as of Q4 2023.

Based on State of New Jersey Common Pension Fund D's 13F filing for Q4 2023, filed 2 Feb 2024.